WallStSmart

CBIZ Inc (CBZ)vsThomson Reuters Corporation Common Shares (TRI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Thomson Reuters Corporation Common Shares generates 177% more annual revenue ($7.66B vs $2.77B). TRI leads profitability with a 19.9% profit margin vs 5.6%. CBZ appears more attractively valued with a PEG of 1.04. CBZ earns a higher WallStSmart Score of 70/100 (B).

CBZ

Strong Buy

70

out of 100

Grade: B

Growth: 8.0Profit: 6.5Value: 6.7Quality: 5.0
Piotroski: 5/9Altman Z: 1.52

TRI

Buy

60

out of 100

Grade: C+

Growth: 5.3Profit: 7.5Value: 4.7Quality: 6.5
Piotroski: 5/9Altman Z: 2.63
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CBZUndervalued (+12.4%)

Margin of Safety

+12.4%

Fair Value

$34.79

Current Price

$54.90

$20.11 discount

UndervaluedFair: $34.79Overvalued
TRISignificantly Overvalued (-52.5%)

Margin of Safety

-52.5%

Fair Value

$58.50

Current Price

$106.34

$47.84 premium

UndervaluedFair: $58.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBZ4 strengths · Avg: 8.0/10
P/E RatioValuation
16.6x8/10

Attractively priced relative to earnings

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
25.6%8/10

Strong operational efficiency at 25.6%

EPS GrowthGrowth
37.7%8/10

Earnings expanding 37.7% YoY

TRI2 strengths · Avg: 9.5/10
Operating MarginProfitability
30.3%10/10

Strong operational efficiency at 30.3%

Debt/EquityHealth
0.219/10

Conservative balance sheet, low leverage

Areas to Watch

CBZ4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.3%4/10

1.3% revenue growth

Altman Z-ScoreHealth
1.524/10

Distress zone — elevated risk

Profit MarginProfitability
5.6%3/10

5.6% margin — thin

Debt/EquityHealth
1.053/10

Elevated debt levels

TRI1 concerns · Avg: 4.0/10
P/E RatioValuation
28.2x4/10

Moderate valuation

Comparative Analysis Report

WallStSmart Research

Bull Case : CBZ

The strongest argument for CBZ centers on P/E Ratio, Price/Book, Operating Margin. PEG of 1.04 suggests the stock is reasonably priced for its growth.

Bull Case : TRI

The strongest argument for TRI centers on Operating Margin, Debt/Equity. Profitability is solid with margins at 19.9% and operating margin at 30.3%. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : CBZ

The primary concerns for CBZ are Revenue Growth, Altman Z-Score, Profit Margin.

Bear Case : TRI

The primary concerns for TRI are P/E Ratio.

Key Dynamics to Monitor

CBZ profiles as a value stock while TRI is a mature play — different risk/reward profiles.

CBZ carries more volatility with a beta of 0.99 — expect wider price swings.

TRI is growing revenue faster at 9.8% — sustainability is the question.

TRI generates stronger free cash flow (349M), providing more financial flexibility.

Bottom Line

CBZ scores higher overall (70/100 vs 60/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CBIZ Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

CBIZ, Inc. provides financial, insurance and advisory services in the United States and Canada. The company is headquartered in Cleveland, Ohio.

Thomson Reuters Corporation Common Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Thomson Reuters Corporation provides business information services in the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Want to dig deeper into these stocks?